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Abstract 15 
Introduction: Continuous intrapartum fetal monitoring remains a significant clinical 16 
challenge. We propose utilising cohorts of routinely collected data. We aim to combine non-17 
classical (data-driven) and classical cardiotocography (CTG) features with clinical features 18 
into a system (OxSys), which generates automated alarms for the fetus at risk of intrapartum 19 
hypoxia. We hypothesise that OxSys can outperform clinical diagnosis of ‘fetal distress’, 20 
when optimised and tested over large retrospective datasets. 21 
Material and Methods: We studied a cohort of 22,790 labouring women (≥36 weeks 22 
gestation). Paired umbilical blood analyses were available. Perinatal outcomes were defined 23 
by objective criteria (Normal; Severe, Moderate or Mild compromise). We used the data 24 
retrospectively to develop a prototype of OxSys, by relating its alarms to perinatal outcome, 25 
and comparing its performance against standards achieved by bedside diagnosis.  26 
Results:  27 
OxSys1.5 triggers an alarm if the initial trace is nonreactive or the Decelerative Capacity (a 28 
non-classical CTG feature), exceeds a threshold, adjusted for preeclampsia and thick 29 
meconium. There were 187 newborns with Severe, 613 with Moderate and 3,197 with Mild 30 
compromise; and 18,793 with Normal outcome. OxSys1.5 increased the sensitivity for 31 
compromise detection: 43.3% vs. 38.0% for Severe (p=0.3) and 36.1% vs. 31.0% for 32 
Moderate (p=0.06); and reduced the false positive rate (14.4% vs. 16.3%, p<0.001).  33 
Conclusions: Large historic cohorts can be utilised to develop and optimise computerized 34 
CTG monitoring, combining clinical and CTG risk factors. Our simple prototype has 35 
demonstrated the principle of  using such data to trigger alarms, and compares well to clinical 36 
judgement. 37 
Keywords: intrapartum fetal monitoring, computerized electronic fetal monitoring, CTG, 38 
sensitivity and specificity. 39 
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Abbreviations 44 
CTG – cardiotocography 45 
OxSys – Oxford System for computerized intrapartum fetal monitoring 46 
FDclin – Operative delivery in clinical practice for the clinical diagnosis of fetal distress 47 
DC – Decelerative Capacity, a computerized feature of the CTG 48 
 49 
 50 
Key Message 51 
Large historic cohorts can be utilised to develop and optimise (prior to clinical testing) 52 
systems for data-driven computerized intrapartum monitoring that combine clinical and CTG 53 
risk factors. 54 
55 
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Introduction   56 
Cardiotocography (CTG) is widely used to continuously monitor the fetus during labour but 57 
its benefits are debated. Meta-analysis suggests that its routine use has a beneficial effect on 58 
the incidence of neonatal seizures (1). But it does not improve rates of cerebral palsy or 59 
perinatal mortality – while increasing instrumental and cesarean deliveries significantly (2). 60 
On the other hand, the technique has been credited by many with reducing the rate of 61 
intrapartum stillbirth: over the time that CTG was introduced intrapartum, stillbirth rates, in 62 
particular those associated with intrapartum hypoxia (3), have reduced. CTG is a possible 63 
cause for at least part of this improvement.  64 
In this regard clinicians are trapped between two uncertainties. They are uncertain that CTG 65 
helps, but equally uncertain that it does not; and reluctant to discard a well-rehearsed 66 
technique with evidence from experience and basic research that it is effective, at least in 67 
part.  68 
Important limitations of the current practice of visual and subjective fetal monitoring include 69 
a high false positive rate, which can lead to unnecessary cesarean or instrumental births (1,4); 70 
and a relatively low sensitivity, such that some babies at risk are not delivered in a timely 71 
fashion. Both are important, and shortcomings in labour management and CTG interpretation 72 
are leading causes for healthcare litigation (5). In USA, the litigation crisis has led some to 73 
suggest abandoning CTG altogether (6,7). Adjunct methods, such as fetal scalp blood 74 
sampling, fetal ECG analysis (such as STAN) and pulse oximetry have shown no consistent 75 
benefits (8-11). 76 
The complex CTG patterns associated with fetal hypoxia are generally assessed visually; 77 
these have been shown to be poorly reproducible and inconsistent (12-14). However, CTG 78 
features can also be measured using computerized numerical analysis, which resolves this 79 
lack of reproducibility. Intrapartum, there are computerized systems that replicate “expert 80 
opinion” (15-19).  In two randomised clinical trials, one showed no difference between 81 
computerized and subjective analysis (18); and the results from the other (INFANT (19)) are 82 
awaited. These systems merely emulate expert clinical assessment and have not been 83 
optimised on data to maximise the detection of adverse perinatal outcomes / minimise the 84 
false positive rate. In our opinion, computerization should go further: to use historic “big 85 
data” to discover new CTG features not apparent to the eye, measure relationship to outcome, 86 
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estimate the effect of confounding variables; ascertain the additive effect of clinical factors; 87 
and determine the background rates of CTG changes in the total population.  88 
Based on this data-driven concept, we present here for the first time OxSys, an early 89 
prototype system demonstrating that non-classical and classical CTG features can be 90 
combined with clinical features to generate automated alarms for the fetus at risk of 91 
intrapartum hypoxia. The aims are, firstly, to demonstrate how cohort data can be used as a 92 
framework for development and evaluation of computerized CTG; and secondly to show how 93 
this enabled us to optimise the diagnostic accuracy of our early prototype system and test it in 94 
a way that is applicable to any similar CTG system.  95 
Materials and Methods 96 
Aim 1: Creating a framework for evaluation 97 
The core composition of the Oxford archive has been described before (20,21) (Fig. 1). A 98 
total of 22,790ss births (dataset Cord gases) were included in this study. Singleton 99 
pregnancies were selected for the completeness of their CTG records acquired in routine 100 
clinical practice (both external and internal fetal monitoring was included); these constituted 101 
anonymized data from women in labour at 36 weeks of gestation or later, from March 2000 102 
until December 2011 at the John Radcliffe Hospital, Oxford (Fig. 1). The study period ended 103 
in 2011 when our unit transferred to a new clinical data collection system. Pregnancies were 104 
excluded for problems that might affect the fetal responses to hypoxic stress, which would 105 
need separate scrutiny, such as prematurity, congenital malformations or breech delivery 106 
(Fig. 1). 107 
Digitised intrapartum CTG data (sampled at 4 Hz) were archived by a central monitoring 108 
system. Clinical details were derived from the Oxford Clinical Maternity database and 109 
included basic maternal demographic and historical data, details of labour, delivery and 110 
perinatal outcome, including umbilical cord blood samples. The latter were considered to be 111 
valid if the difference between venous and arterial pH was at least 0.02 (22). The primary 112 
reason for cesarean or vaginal operative delivery at the time of the intevention (if applicable) 113 
was recorded electronically immediately after birth by the attending clinician. A drop down 114 
menu was used allowing eight possible reasons (fetal distress, failure to progress, prolonged 115 
second stage, placenta praevia, multiple birth, malpresentation, severe preeclampsia, previous 116 
obstetric history). This electronic record allowed us to distinguish a clinical diagnosis of fetal 117 
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distress (FDclin) from other reasons for operative delivery but the precise time when the 118 
decision for operative delivery was taken, was not documented electronically. Only the 119 
records with validated cord gas analyses were included in this study (Fig. 1). 120 
All CTG records, archived on our server were available for this retrospective analysis. For 121 
each woman, the entire CTG record was analysed. Those stopped three hours or more before 122 
delivery were excluded, because they could have little relevance to the analysis of features 123 
leading to obstetric intervention and/or affecting the condition of the baby at birth. Short 124 
fragments of CTG traces, less than 15 minutes long, were also excluded. Most traces (80%) 125 
ended less than five minutes before birth, with 93% ending less than 20 minutes and only 2% 126 
ending longer than 60min before birth. 127 
Perinatal outcomes were classified into four exclusive groups (Table 1), defined 128 
pragmatically. Severe adverse outcome was defined as a composite outcome while . moderate 129 
and mild adverse outcomes were defined by the degree of acidemia in umbilical arterial 130 
blood. 131 
We established when operative delivery was for FDclin in each of the outcome groups. In 132 
parallel, retrospective occurrences of OxSys1.5 alarms were defined, which enabled us to 133 
compare OxSys to clinical management in terms of: 134 
- The detection rates of  different groups of adverse outcomes. 135 
- The false positive rate, that is the comparative rates of positive tests associated with 136 
normal outcomes. 137 
- A “dose-response” effect, i.e. whether an increasing number of alarms or 138 
interventions were observed in the outcomes with worsening compromise from Mild 139 
to Severe. 140 
The framework we present is a method whereby computerized CTG analysis systems could 141 
be tested on a comprehensive database of unselected cases, which includes paired cord blood 142 
gas analyses at birth and, crucially, prospectively collected classification of the reasons for 143 
operative delivery during labour. The framework allows the likely utility of computerized 144 
CTG analysis systems to be evaluated; and allows calculation of effect size, sensitivity, false 145 
positive rates and potentially sample size to be estimated prior to prospective evaluation. In 146 
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this report we give the proof of principle of this method by evaluating our own computerized 147 
CTG system (an early prototype). This is described in Aim 2. 148 
Aim 2: Applying the methodology to establish a prototype system for computerized 149 
intrapartum CTG analysis.  150 
We assessed an early prototype computerized CTG system (The Oxford System, OxSys 1.5). 151 
The CTG is analysed in 15min windows; these move forward every five minutes, when the 152 
analysis is updated, on the basis of being a clinically relevant rate. This continues until an 153 
alarm is triggered or delivery, whichever occurs first. OxSys 1.5 is largely based on one 154 
computerized parameter – the decelerative capacity (DC) of Phase Rectified Signal 155 
Averaging (23-25). ‘Decelerative capacity’ analyses the entire fetal heart rate signal within 156 
the 15 minute analysis window, including accelerations and decelerations. It provides an 157 
average measure of downward movements in the fetal heart rate. Lower values are measured 158 
in a normal trace without significant decelerations. If the trace has many accelerations, these 159 
increase the DC but it remains well within the normal range (2bpm to 4bpm, data not shown). 160 
However, DC increases significantly if there are deep, steep-sloped and/or frequent 161 
decelerations. In effect,  DC is a measure that combines both the time the trace spends at 162 
baseline and the frequency and depth of decelerations. Non-reactive traces have very low DC. 163 
DC has been confirmed to increase at the time of induced cord occlusion in the fetal lamb 164 
model of intrauterine hypoxic-ischaemic stress (24). The specific DC parameters were set as 165 
in our previous work (23). Based on an iterative process that uses both clinical knowledge 166 
and mathematical optimisation (26,27), we established the current system configuration 167 
(OxSys 1.5): a single OxSys alarm is triggered if: (1) the first hour of the trace is flat and 168 
non-reactive (DC value below 1bpm without accelerations, (28)); or (2) the DC reaches a 169 
defined threshold at any point during labour. The threshold is adjusted to a lower value if 170 
there is thick meconium or preeclampsia or to a higher value otherwise. A single OxSys 171 
alarm is required in order for us to count the alarm as a true or false positive. 172 
Only CTG segments with valid signal in at least 50% of the time (signal quality) and only 173 
alarms that occurred 15 minutes or longer before the time of birth were considered. This is 174 
because alarms triggered nearer to the time of delivery would have been ‘too late’ to 175 
influence management.  176 
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The study was approved by the Newcastle & North Tyneside 1 Research Ethics Committee, 177 
REC reference 11/NE/0044 (data before 2008) and the South Central Ethics Committee, REC 178 
reference 13/SC/0153 (data beyond 2008). Informed consent was not required.  179 
Results 180 
The demographic characteristics of the women are reported in Table 2. The dataset Cord 181 
gases (included in our analysis in this study) had a higher rate of operative deliveries than the 182 
cohort from which it was derived, Birth indication (all monitored deliveries in March 2000-183 
December 11).  Also, slightly more babies showed thick meconium.  184 
Dataset Cord gases includes 187 babies with Severe compromise. The clinical sensitivity or 185 
ability to detect Severe compromise during labour is 37.97% (Table 3). Thus, this project has 186 
enough power (α=0.05, β=0.1, two-sided Wald test) to detect significantly higher sensitivity 187 
for OxSys at 50% or above. 188 
The size of the database is crucial for reliable estimation of the rate of OxSys alerts in 189 
Normals (false positive rate). A decrease in false positive rate of ≥0.7% can be detected in 190 
Cord gases (α=0.05, β=0.1, two-sided Wald test), compared to the estimated rate of clinical 191 
intervention in Normal – 16.33% (Table 3). 192 
Optimisation and diagnostic accuracy of current prototype (OxSys1.5) 193 
We utilised the above framework to iteratively develop a diagnostic system prototype 194 
(illustrated in Fig. 2): we began with a very simple prototype: one triggering an alarm if at 195 
any point the DC passed a single threshold (5.8bpm). After further experiments, we 196 
established that the sensitivity for severe compromise can be improved (without worsening 197 
the false positive rate) if the DC threshold was lowered to 4bpm in the presence of thick 198 
meconium or preeclampsia, which are well known clinical risk factors, and increased to 199 
6.8bpm otherwise. These thresholds were selected after optimisation on the data. 200 
Furthermore, we established that the sensitivity to severe compromise was increased further 201 
if an alarm was also triggered in the rare cases where the initial CTG trace was nonreactive 202 
(Fig. 2).  203 
The sensitivities of detecting Severe, Moderate or Mild adverse outcomes both by clinical 204 
assessment and OxSys1.5  are presented in Table 3. The detection rates for compromise types 205 
were consistently in favour of OxSys1.5 but the differences were statistically significant only 206 
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if Severe and Moderate compromise were combined into one category: 32.6% vs. 37.8%, Chi 207 
squared test, p=0.03.  208 
The false positive rates can be measured in the Normal outcome group, in whom a clinical 209 
decision was taken to intervene (FDclin) or the computerized system caused an “alarm”. Here 210 
the respective figures were 16.3% for FDclin and 14.5% for OxSys1.5, (p<0.001) 211 
Thus OxSys1.5 is associated with comparable or higher sensitivity and significantly lower 212 
false positive rates when compared to clinical diagnosis. A dose-response relationship was 213 
demonstrated for both FDclin and OxSys: there was an increasing rate of alarms from Normal 214 
through Mild and Moderate to Severe. Furthermore, the rates of both FDclin and OxSys alarms 215 
declined with increasing pH threshold, in parallel, with OxSys alarm rates being consistently 216 
higher (Fig. 3), demonstrating a dose-response relationship. 217 
An important aspect of intrapartum CTG is the degree of urgency of delivery when the 218 
monitoring is abnormal. Only carefully conducted prospective studies can show how useful 219 
the system is in this regard. We can retrospectively determine how long before birth an alarm 220 
would have been triggered by OxSys (the Alarm to Delivery (A-D) interval). This interval 221 
must be long enough to allow time for operative delivery. The minimal acceptable A-D 222 
interval depends on the clinical context, e.g. whether the woman is in the second stage of 223 
labour.  224 
The results reported in Table 3 of our manuscript used an A-D of 15 minutes. However we 225 
also investigated varying A-D intervals (from 0 to 60min) and stratified the analysis 226 
according to the labour stage. In the first stage of labour, the performance of OxSys would 227 
have been similar if the A-D interval had been 60min. However, in the second stage of 228 
labour, the alarm rates  quickly reduced as the A-D interval rose from 0min to 60min: only 229 
45% of alarms in the second stage were raised 45min or more before birth, and 25% were 230 
raised 60min or earlier. Hence an alarm in the first stage of labour in most instances gave a 231 
reasonable warning time of at least 60 minutes; the shorter warning time in the second stage 232 
of labour is to be expected and is not necessarily incompatible with timely intervention.  233 
Overall, regardless of labour stage, around 40% of OxSys alarms in babies with Severe 234 
compromise and about 20% in those with Moderate, were trigerred more than five hours prior 235 
to birth. 236 
Discussion 237 
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We describe for the first time a methodology with which computerized CTG interpretation 238 
can be evaluated and compared to clinical assessment, using the same historic cohort data and 239 
identical measures of diagnostic accuracy. In this retrospective study, operative delivery was 240 
used to expedite delivery because of fetal distress (FDclin) in 37.97% of cases with Severe 241 
adverse outcome and in 31.00% of those with Moderate. The rate of unnecessary intervention 242 
due to fetal distress was, as is generally believed, very high: over 16% interventions in the 243 
Normal group (a third of these were Caesareans and two thirds were vaginal operative 244 
deliveries). The simple prototype system presented here (OxSys1.5) already performed at 245 
least as well, if not slightly better, than clinical assessment (both in terms of higher sensitivity 246 
and lower false positive rate). In future work, we will adopt the framework and iterative 247 
development process illustrated here (Fig. 2), to define additional rules for triggering alarms. 248 
These will be added to OxSys to ensure a significantly better system prototype with 249 
substantially higher clinical utility. 250 
The strengths of this study include our large cohort of high quality detailed data. We also 251 
considered various perinatal outcomes and the effects of different arterial pH thresholds (Fig. 252 
3). Our data spans years and clinical practice has inevitably changed in that time. However, 253 
there was no evidence of any temporal change to the performance of OxSys during the study 254 
period (data not shown). Furthermore, a system that works well on a cohort spanning years of 255 
varying clinical practice, will be better positioned to work well on new data, than one 256 
designed with data from a narrow snapshot of clinical practice. 257 
Retrospective data to evaluate methods for CTG have been previously used (18,34). The 258 
performance of PeriCALM (marketed by PeriGen), which simulates clinical expert 259 
assessment has been reported (34). However, the cases were selected based on being either 260 
severely compromised or with no signs of acidosis. Hence, a valid false positive rate is not 261 
available. In another study of >8000 deliveries the sensitivity of significant ST events from 262 
STAN monitoring (Neoventa Medical), (18) to predict arterial pH<7.05 was found to be 263 
44.4%; this is higher than in our study (37.3% for OxSys) but at a higher alarm rate for all 264 
babies with arterial pH≥7.05 of 19.2% for STAN (16.1% for OxSys). It must be remembered 265 
that for STAN, accurate evaluation of CTG is also necessary, and combining STAN with 266 
OxSys is an interesting future possibility. 267 
There are also inherent limitations and considerations, which are valid for any work with 268 
intrapartum CTG analysis: 269 
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Firstly, retrospective studies have inherent biases, and these can affect analysis of CTG data 270 
(30). A higher false positive rate and lower sensitivity is expected in populations with lower 271 
prevalence of compromise, but the proposed diagnostic methods are still valid, because the 272 
basic pathophysiological relationship between CTG patterns and compromise is universal.  273 
Secondly, there is a ‘treatment paradox’: if perinatal compromise has been prevented by 274 
appropriate intervention, it could present as a false positive – a wider problem in obstetrics 275 
discussed recently (31). In this context, cord blood gas analyses and our definitions of 276 
outcome are important: it is reasonable to assume a false positive intervention in the absence 277 
of acidemia (the Normal group, (32)). However, if there is moderate acidemia, the outcome 278 
could be placed in a category of a prevented true positive (i.e. Moderate or Mild 279 
compromise).  280 
Thirdly, the condition of the baby at birth cannot be known at the time the decision to deliver 281 
is made using CTG (neither in current clinical practice or with computerized alarms). The 282 
CTG is fundamentally limited in its ability to ‘predict’ intrapartum hypoxia – it is only a 283 
surrogate marker of measuremnets that we have no access to (for example fetal blood 284 
pressure, fetal cerebral perfusion, fetal oxygenation, etc.). However, in the absence of such 285 
direct measures, a ‘risk assessment’ approach by identifying a group of fetuses at increased 286 
risk of compromise, needs to be taken.   287 
There are conflicting views as to whether acidemia alone is a valid endpoint of CTG and 288 
clinical obstetrics (30) prompting the need to define separate severe and moderate 289 
compromise groups. However, not all severe compromises have an intrapartum cause and are 290 
preventable by CTG monitoring: the fact that it cannot often be established whether a baby’s 291 
injury was due to labour and/or preventable, is a wider challenge in clinical practice, 292 
litigation and CTG research. Therefore, we have kept an open mind about the aetiology of 293 
perinatal cerebral injury and proposed one overarching study design, by focusing on both 294 
clinically important severe compromise and different grades of academia. Our definitions of 295 
perinatal outcomes (Table 1) are based in part on umbilical arterial blood gas measurements 296 
at birth. Although there is no consensus as to how acidemia is best measured we have 297 
previously demonstrated that pH is preferable to Base Deficit (BD) (21). Moreover, in our 298 
study, 96% of the newborns with pH<7.05 had a BD>10mmol/l and 85% >12mmol/l. In Fig. 299 
3, we demonstrate the effect of changes in pH thresholds, which amounts to a graded (and 300 
mechanistically reasonable) dose response effect.  301 
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Finally, CTG recordings during labour often may have poor quality leading to 302 
misinterpretation and uncertainty. This is a problem both in visual and computerized CTG 303 
interpretation. There are further limitations of the techniques for CTG acquisition, with 304 
rounding off errors and lack of ‘true’ beat to beat detailed data (as available in adult heart rate 305 
analysis).  306 
All of the above limitations are inherent to CTG monitoring in clinical practice and our study 307 
does not claim to resolve these. Instead, our work proposes that further progress is possible 308 
despite these limitations and we propose to develop future OxSys versions with these 309 
considerations in mind.   310 
At this stage, our early prototype has limited clinical utility. But we advocate the future 311 
development of refined systems using our framework to allow objective, standardised 312 
reporting and comparison between the diagnostic accuracies of different methods for CTG 313 
interpretation. Further work will examine the patterns of those fetuses with Severe 314 
compromise that were unrecognized and of those that triggered false alarms, generating new 315 
hypotheses about important CTG patterns. Any new hypotheses can be rapidly tested using 316 
the data leading to an iterative development of scientific, evidence-based methods for CTG 317 
interpretation. This means that computerized CTG can be extensively optimised before 318 
expensive clinical trials. In this regard validation on different independent datasets is 319 
essential prior to prospective clinical testing. 320 
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  415 
 416 
Tables  417 
Table 1. Definitions of the outcome groups and incidence in the dataset included in analysis.  418 
 419 
420 
 
 
Exclusive outcome groups 
Data included in this 
study: dataset Cord 
gases, n = 22,790 
Severe  Composite outcome of: stillbirth; neonatal death; 
neonatal encephalopathy; intubation or cardiac massage 
followed by admission to neonatal intensive care for 
≥48hrs. 
187 (0.82%) 
Moderate Umbilical cord arterial pH<7.05 without severe 
compromise 
613 (2.69%) 
Mild 7.05 ≤ pH < 7.15 without severe compromise 3,197 (14.03%) 
Normal pH >= 7.15  without severe compromise 18,793 (82.46%) 
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Table 2. The Oxford datasets: clinical and demographic characteristics: n (%). The datasets 421 
are defined in Fig. 1. 422 
 
All  
(58,748)  
Birth indication 
(38,818) 
Cord gases  
(22,790) 
Nulliparous 
32,523 (55.36%) 21,927 (56.49%) 13,948 (61.20%) 
Pre-eclampsia 
6,303 (10.73%) 3,497 (9.00%) 2,282 (10.01%) 
Gestational Diabetes 
509 (0.87%) 423 (1.09%) 262 (1.15%) 
Induction of labour 
25,157 (42.82%) 17,966 (46.28%) 10,838 (47.56%) 
Cesarean or Forceps/Ventouse 
delivery 
22,432 (38.18%) 
15,594 (40.17%) 11,382 (49.94%) 
Cesarean 
7,080(12.05%) 5,164 (13.30%) 3,908 (17.15%) 
Thick meconium 
4,531 (7.71%) 3,437 (8.85%) 2,474 (10.86%) 
Oxytocin 
22,062 (37.55%) 15,295 (39.40%) 9,783 (42.93%) 
Low Apgar 
1,448 (2.47%) 1,008 (2.60%) 782 (3.43%) 
Severe compromise 
473 (0.81%) 255 (0.66%) 167 (0.79%) 
Convulsions 
109 (0.18%) 74 (0.19%) 50 (0.22%) 
Neonatal encephalopathy 
164 (0.28%) 80 (0.20%) 51 (0.22%) 
Intubation or cardiac massage 
614 (1.05%) 318 (0.82%) 247 (1.08%) 
SCBU admission ≥ 48hrs 
2,910 (3.25%) 1,215 (3.13%) 811 (3.56%) 
Small baby (<3rd centile§) 
936 (1.59%) 575 (1.48%) 346 (1.52%) 
Large baby (>97th centile§) 
2,922 (4.97%) 
1,953 (5.03%) 
1,282 (5.64%) 
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§ adjusted Yudkin (29) centile. 423 
 424 
425 
Stillbirth 
2 (0.0034%) 
1 (0.0026%) 
0 (0.00%) 
Neonatal death (<28 days)   
30 (0.05%) 
22 (0.06%) 
17 (0.07ss%) 
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 426 
Table 3. OxSys1.5 alarm rate and emergency deliveries in clinical practice due to fetal 427 
distress (FDclin): number (%) [95% confidence interval].  428 
 429 
* 906 (29.5%) of these were Cesarean sections; 430 
Chi squared test, OxSys 1.5 vs. Clinicians: ** p = 0.29; *** p = 0.06; †p < 0.04; ‡ p<0.001. 431 
 432 
 433 
 434 
 435 
Figures 436 
 437 
Fig. 1. Data flow chart. – in separate pdf. 438 
 439 
 440 
 441 
Diagnostic accuracy on Cord gases dataset (n=22,790) 
Exclusive outcome 
groups 
Compromise (sensitivity) Normal  
(false positive rate) 
Severe Moderate Mild 
Number of births 187 613 3,197 18,793 
Detected in clinical 
practice (FDclin) 
71 (37.97%) 
[31.0%-44.9%] 
190 (31.00%) 
[27.3%-34.7%] 
719 (22.49%) 
[21.0%-23.9%] 
3,068 (16.33%)* 
[15.8%-16.9%] 
Detected by  
OxSys 1.5 
81 (43.32%)** 
[36.2%-50.4%] 
221 (36.05%)*** 
[32.2%-39.9%] 
789 (24.68%)† 
[23.2%-26.8%] 
2,710 (14.42%)‡ 
[13.9%-14.9%] 
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 442 
Fig. 2. OxSys evolution throught the iteration phases: the sensitivity of the system improved 443 
significantly (p<0.001) without increasing the false positive rate, Cord gases dataset (n = 444 
22,790).  445 
 446 
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Fig. 3.  The rate of emergency interventions for fetal distress (FDclin) and the OxSys1.5 alarm 447 
rate (i.e. the sensitivity) consistently increase if lower pH threshold is used to define 448 
increasing acidemia, Cord gases dataset (n = 22,790).  449 
 450 
